Exploring Combination Drug Exposure for Epileptic Pregnant Women

Video

Kimford J. Meador, MD speaks about the neurodevelopment effects of combination drug exposure in women with epilepsy at the American Epilepsy Association 2014 Annual Meeting.

Kimford J. Meador, MD speaks about the neurodevelopment effects of combination drug exposure in women with epilepsy at the American Epilepsy Association 2014 Annual Meeting.

Meador commented, "There are a lot of seizure medications that we don't understand the risks or the combinations very well. Most women with epilepsy go through pregnancy on a single drug, but there's a reasonable subset of anywhere from 20-33% of women that are on polytherapy and we don't know those combinations may increase risks."

Related Videos
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
© 2024 MJH Life Sciences

All rights reserved.